Minnesota’s medical marijuana law was first passed in 2014, enacted in 2015, and revised to include post-traumatic stress disorder (PTSD) in 2016. Still a work in progress, officials within the Minnesota Department of Health (MDH) will debate the expansion of the state’s medical cannabis program today – Tuesday, Oct. 10 – at the State Office Building in St. Paul Minnesota at 1 p.m.
Autism, nausea, dementia, Parkinson’s disease, peripheral neuropathy, and a host of other medical conditions will be considered as qualifying ailments by the MDH at today’s meeting.
One of the more tightly regulated medical marijuana programs in the country, Minnesota’s current list of qualifying illnesses is limited to these 11 conditions:
- Cancer/wasting syndrome
- Glaucoma
- HIV/AIDS
- Tourette Syndrome
- ALS (Amyotrophic Lateral Sclerosis)
- Epilepsy
- Multiple Sclerosis, muscle spasms
- Crohn’s disease/inflammatory bowels
- Terminal Illness – life expectancy of less than one year
- Intractable pain
- Post-Traumatic Stress Disorder